Stockreport

Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024

Vaxxinity, Inc.  (VAXX) 
PDF CAPE CANAVERAL, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today an [Read more]